Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 6Unknown 3Recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Genitourinary 3Gastrointestinal 3Sarcoma 2Other solid neoplasm 2Breast 2Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Hyperthermia 2Rectal Neoplasms 1Pancreatic Neoplasms 1Anus Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Diathermy × Gastrointestinal × Clear all
NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown
59 enrolled
Gastrointestinal

Hyperthermia, Rectal Neoplasms

NCT02369939 2017-08-11

HYCAN

University of Erlangen-Nürnberg Medical School

Phase 3 Unknown
118 enrolled
Gastrointestinal

Hyperthermia, Anus Neoplasms

NCT00082862 2012-02-13

Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
48 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡